CommSec's Tom Piotrowski speaks with AirXpanders (AXP) CEO, Scott Dodson about:
- AXP’s AeroForm product, which offers a needle-free alternative for women who choose reconstructive surgery following a mastectomy. AeroForm is activated by a handheld wireless controller that administers small amounts of carbon dioxide up to three times a day, to gradually stretch the tissue in preparation for a breast implant.
- The factors that have led to the growth in sales of AeroForm with the product now available in more than 100 medical institutions and health systems in the U.S.
- How AXP is driving increased awareness and enquiry for AeroForm through a successful public relations program.
- AXP’s focus on increasing capacity at the contract manufacturing facility in Costa Rica.
To view other Executive Series interviews, visit (VIEW LINK)